| Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an in vivo model of inflammation by suppressing NF-KB and MAPK Signalling D Thummuri, MK Jeengar, S Shrivastava, H Nemani, RN Ramavat, ... Pharmacological Research 99, 63-73, 2015 | 123 | 2015 |
| p53 amyloid formation leading to its loss of function: implications in cancer pathogenesis S Ghosh, S Salot, S Sengupta, A Navalkar, D Ghosh, R Jacob, S Das, ... Cell Death & Differentiation 24 (10), 1784-1798, 2017 | 119 | 2017 |
| 177Lu-EDTMP: A Viable Bone Pain Palliative in Skeletal Metastasis S Chakraborty, T Das, S Banerjee, L Balogh, PR Chaudhari, HD Sarma, ... Cancer biotherapy & radiopharmaceuticals 23 (2), 202-213, 2008 | 111 | 2008 |
| Preparation and bioevaluation of 166Ho labelled hydroxyapatite (HA) particles for radiosynovectomy PR Unni, PR Chaudhari, M Venkatesh, N Ramamoorthy, MRA Pillai Nuclear medicine and biology 29 (2), 199-209, 2002 | 69 | 2002 |
| Carnosic acid attenuates RANKL-induced oxidative stress and osteoclastogenesis via induction of Nrf2 and suppression of NF-κB and MAPK signalling D Thummuri, VGM Naidu, P Chaudhari Journal of Molecular Medicine 95, 1065-1076, 2017 | 64 | 2017 |
| A polymeric temozolomide nanocomposite against orthotopic glioblastoma xenograft: tumor-specific homing directed by nestin S Prabhu, JS Goda, S Mutalik, BS Mohanty, P Chaudhari, S Rai, N Udupa, ... Nanoscale 9 (30), 10919-10932, 2017 | 51 | 2017 |
| Liposomes for targeting hepatocellular carcinoma: use of conjugated arabinogalactan as targeting ligand SM Shah, PN Goel, AS Jain, PO Pathak, SG Padhye, S Govindarajan, ... International Journal of Pharmaceutics 477 (1-2), 128-139, 2014 | 46 | 2014 |
| Prevention of radiation-induced bystander effects by agents that inactivate cell-free chromatin released from irradiated dying cells Cell Death & Disease 1142, 2018 | 45 | 2018 |
| Target-specific cytotoxic activity of recombinant immunotoxin scFv (MUC1)-ETA on breast carcinoma cells and primary breast tumors R Singh, U Samant, S Hyland, PR Chaudhari, WS Wels, ... Molecular Cancer Therapeutics 6 (2), 562-569, 2007 | 45 | 2007 |
| ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer P Iyer, SV Shrikhande, M Ranjan, A Joshi, N Gardi, R Prasad, ... International journal of cancer 144 (8), 2008-2019, 2019 | 44 | 2019 |
| Multiple layer formation of bovine serum albumin on silver nanoparticles revealed by dynamic light scattering and spectroscopic techniques M Waghmare, B Khade, P Chaudhari, P Dongre Journal of Nanoparticle Research 20, 1-21, 2018 | 42 | 2018 |
| Synthesis, biological evaluation, and molecular docking analysis of phenstatin based indole linked chalcones as anticancer agents and tubulin polymerization inhibitors J Kode, J Kovvuri, B Nagaraju, S Jadhav, M Barkume, S Sen, ... Bioorganic Chemistry 105, 104447, 2020 | 41 | 2020 |
| Drug-sensitiveFGFR3 mutations in lung adenocarcinoma P Chandrani, K Prabhash, R Prasad, V Sethunath, M Ranjan, P Iyer, ... Annals of oncology 28 (3), 597-603, 2017 | 41 | 2017 |
| Enhanced skin permeation of Methotrexate from penetration enhancer containing vesicles: In vitro optimization and in vivo evaluation B Sadarani, A Majumdar, S Paradkar, A Mathur, S Sachdev, B Mohanty, ... Biomedicine & Pharmacotherapy 114, 108770, 2019 | 40 | 2019 |
| Sentinel lymph node detection in canine oncological patients L Balogh, J Thuróczy, G Andocs, D Mathé, P Chaudhari, E Perge, I Biksi, ... Nucl Med Rev 5 (2), 1-6, 2002 | 37 | 2002 |
| 186Re-1, 4, 8, 11-tetraaza cyclotetradecyl-1, 4, 8, 11-tetramethylene phosphonic acid: a novel agent for possible use in metastatic bone-pain palliation K Kothari, G Samuel, S Banerjee, PR Unni, HD Sarma, PR Chaudhari, ... Nuclear medicine and biology 28 (6), 709-717, 2001 | 36 | 2001 |
| Accentuated osseointegration in osteogenic nanofibrous coated titanium implants S Das, K Dholam, S Gurav, K Bendale, A Ingle, B Mohanty, P Chaudhari, ... Scientific Reports 9 (1), 17638, 2019 | 32 | 2019 |
| Design of cholesterol arabinogalactan anchored liposomes for asialoglycoprotein receptor mediated targeting to hepatocellular carcinoma: In silico modeling, in vitro and in … P Pathak, V Dhawan, A Magarkar, R Danne, S Govindarajan, S Ghosh, ... International Journal of Pharmaceutics 509 (1-2), 149-158, 2016 | 32 | 2016 |
| Cyclopentadienyl technetium (99mTc) tricarbonyl piperidine conjugates: biodistribution and imaging studies M Saidi, K Kothari, MRA Pillai, A Hassan, HD Sarma, PR Chaudhari, ... Journal of Labelled Compounds and Radiopharmaceuticals: The Official Journal …, 2001 | 30 | 2001 |
| Preparation and biological evaluation of 153Sm-DOTMP as a potential agent for bone pain palliation S Chakraborty, T Das, S Banerjee, PR Chaudhari, HD Sarma, ... Nuclear medicine communications 25 (12), 1169-1176, 2004 | 29 | 2004 |
B. B. MohantyProfessor, Department of Sociology, Pondicherry University, Puducherry - 605 014.Verified email at pondiuni.edu.in
